From: Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy
Study sample, n = 91 n (%) | Non-responders, n = 41 n (%) | |
---|---|---|
Male | 73 (82) | 36 (86) |
Insurance | ||
Medicaid | 52 (57) | 27 (66) |
Uninsured | 23 (25) | 8 (20) |
Medicare | 10 (11) | 0 (0) |
Private | 9 (10) | 6 (15) |
Race/Ethnicity | ||
Caucasian | 38 (42) | 12 (29) |
African-American | 34 (37) | 17 (42) |
Hispanic | 18 (20) | 12 (29) |
Asian | 1 (1) | 0 (0) |
Buprenorphine treatment history | ||
Median buprenorphine dose, (range) | 20 mg/day (1.5, 24) | 16 mg/day (1, 24) |
Mean time in treatment (months), (range) | 28 (1, 71) | 32 (1, 75) |